Fresenius Kabi Bidiphar, a joint venture health care company, opened its new production facility in the coastal city of Quy Nhon in central Vietnam on September 26.
Frsenius Kabi Bidiphar SJC is a joint-venture between Frsenius Kabi, a market leader in infusion therapy and clinical nutrition, and Bidiphar, a state-owned health care company in Quy Nhon.
Fresenius Kabi Bidiphar is focused on therapy and care of critically and chronically ill patients inside and outside the hospital. The company’s new production plant will employ nearly 380 employees.
The production plant, built at a cost of approximately VND340 billion (US$16 million), will produce around 50 million infusion tubs and 130 million injection bottles per year, which have already been certified by Good Manufacturing Practice guideline standards set by the World Health Organization.
The new production plant is spread out over an area of 15,000 square meters.